Given that hepatocytes commonly express insulin receptors, we hypothesize that endogenous hyperinsulinemia may partly drive hepatic secretion of LEAP2 in patients with insulinoma (Figure 4). Here, LEAP2 is linked to pancreatic insulinoma.